Every Innovation Begins with a Single Patient

I am honored to congratulate the Editorial Board, reviewers, authors, and the entire AME Publishing team on the achievement of an official Impact Factor for AME Case Reports. This important milestone reflects the journal's unwavering commitment to scientific quality, educational value, and international collaboration.

Throughout my career as a cardiovascular surgeon, I have treated many patients with complex aortic diseases, valvular heart disorders, and high-risk conditions, including transfusion-free cardiac surgery. These experiences have continually reinforced one important belief: every medical innovation begins with a single patient. Before new concepts are incorporated into guidelines or supported by large clinical trials, they often originate from carefully observed and thoughtfully reported individual cases.

For this reason, I consider case reports not as the lowest level of evidence, but as the foundation of clinical innovation. They preserve invaluable experiences, encourage critical thinking, generate new hypotheses, and provide practical lessons that may benefit patients around the world. Particularly in cardiovascular surgery, where each operation presents unique anatomical and technical challenges, sharing these experiences is essential for advancing our field.

AME Case Reports has created an outstanding international platform where clinicians can exchange meaningful experiences with scientific rigor and educational purpose. The journal has successfully connected physicians across specialties and countries, fostering collaboration and continuous learning. The newly awarded Impact Factor is a well-deserved recognition of these efforts.

Looking ahead, I hope the journal will continue to encourage reports of innovative surgical techniques, multidisciplinary decision-making, ethical challenges, and long-term clinical outcomes. Such contributions will not only strengthen the journal's academic influence but also inspire the next generation of clinicians and surgeon-scientists.

It has been a privilege to contribute to AME Case Reports, and I look forward to witnessing its continued growth as one of the leading international journals dedicated to high-quality clinical case reports.

I would like to congratulate the all team of the AME Case Reports (ACR) for the new impact factor. As a urologist, I observe that ACR has improved the quality of the published clinical cases more and more. I am glad to be able to participate in this journey. Go ahead!

With the issuance of the first impact factor for Annals of Eye Science, we celebrate and express deep appreciation for the contributions of all authors, reviewers, staff, editors, and others who have worked tirelessly to make this possible. The field of medical publishing has become increasingly competitive and demanding in recent years, and it takes both scientific excellence and effective organizational workflows to publish quality peer-reviewed articles that meet international standards. We look forward to continued growth of AES as a forum for advancing research and disseminating new clinical knowledge in ophthalmology!

Since I joined the editorial board five years ago, I have witnessed enthusiasm in the team striving for excellence in the performance of the journal. I am delighted to know that ABS has now obtained its first impact factor, marking a significant milestone. Let’s carry on with the good work. Many congratulations!

As both editorial board member and contributor to the Annals of Breast Surgery, the journal brings me great focus to advancing the field of breast surgery through an interdisciplinary lens. This journal uniquely captures the breadth of the specialty, integrating both the foundational principles of basic science and the practicalities of clinical application. By fostering a comprehensive understanding of breast surgery, we can ensure that practitioners are well-equipped with the latest knowledge and techniques necessary for effective patient care. The journal's commitment to covering a diverse array of topics allows for a richer dialogue among surgeons, researchers, and allied health professionals, thereby enhancing our collective efforts toward better outcomes in breast health.

The inclusion of modern technologies and advances in the Annals of Breast Surgery is particularly significant to me, especially as we navigate an increasingly complex healthcare landscape that includes advancements in artificial intelligence (AI). As AI continues to reshape our approach to diagnosis and treatment, embracing these innovations within the journal’s framework is essential. By focusing on cutting-edge research and incorporating AI-driven methodologies, we empower surgeons to stay at the forefront of their practice and deliver more precise, personalized care to patients. This not only elevates the standard of surgical interventions but also provides a platform for critical discussions on the ethical implications and practical applications of these technologies.

Furthermore, my involvement with the Annals of Breast Surgery is driven by a passion for promoting interdisciplinary collaboration. The melding of basic science insights with clinical practice fosters a holistic understanding of breast surgery that transcends traditional boundaries. In an era where the pace of scientific discovery is accelerating, staying informed and adaptable is crucial. The journal serves as an invaluable resource for those in the field, allowing us to continually learn, innovate, and improve our approaches to breast surgery and breast medicine in general, which ultimately translates into better patient care and outcomes.

Congratulations to Annals of Breast Surgery and the excellent colleagues promoting this journal. The journal will go on advancing and sharing the knowledge of breast surgery.